The metabolism of 14 C-4-n-nonylphenol ( 14 C-4-n-NP), as a model for the xenoestrogen nonylphenol, was investigated in three types of tobacco cell suspension cultures: one genetically non-modified culture (NT) and two cultures constitutively expressing human cytochrome P450 CYP1A1 or CYP1A2. With 1 mg l Ð1 of 14 C-4-n-NP and 24 h of incubation, the xenobiotic was transformed almost completely to glycosides. After glycosidic cleavage, 14 C-4-n-NP and several primary metabolites of 14 C-4-n-NP were liberated. Portions of the primary metabolites were 29.3% (NT culture), 34.3% (CYP1A1 culture), and 50.7% of applied 14 C (CYP1A2 culture). Thus, the endogenous capacity of the tobacco cells to form primary metabolites of 4-n-NP was noticeably higher than that of CYP1A1 or CYP1A2. The results however clearly suggest that 4-n-NP is Ð even though a poor Ð substrate of CYP1A1 and CYP1A2. In order to examine metabolic profiles of 4-n-NP in the NT, CYP1A1 and CYP1A2 cultures, the suspensions were exposed to 10 mg l Ð1 of 14 C-4-n-NP using a two-liquid-phase system with carrier n-hexadecane and 192 h of incubation. Results obtained resembled those of the low concentration study. The oxidative metabolic profiles determined after hydrolytic cleavage using GC-EIMS were similar in the NT, CYP1A1 and CYP1A2 cultures. Main metabolites were side-chain mono-hydroxylated derivatives of 4-n-NP with 6Ј-, 7Ј-and 8Ј-OH-4-n-NP as prominent metabolites. In addition, olefinic side-chain hydroxy, ring methoxylated, keto and ring hydroxylated derivatives were observed. The lack of differences in metabolic profiles among the CYP1A1, CYP1A2 and NT cultures was referred to the low enzymatic activity of CYP1A1 and CYP1A2 as compared to the higher endogenous oxidative capacity of tobacco, as well as to similar metabolic profiles of 4-n-NP produced by CYP1A1 and CYP1A2 and tobacco itself.
Introduction
In recent years, valuable information on substrate specificities of P450 isozymes concerning xenobiotics was derived from studies using bacteria (e.g. Parikh et al., 1997) or yeasts (e.g. Inui et al., 2001) heterologously expressing the corresponding genes. Both expression systems show no or only low endogenous P450 activity. In addition, commercially available microsomes containing selected (human) P450 species are utilized, which are derived from the baculovirus expression system. All systems mentioned so far, however, require the co-expression of NADPH-P450 reductase in order to obtain catalytically active P450s. Overexpression of mammalian P450 isozymes in higher plants, e.g. tobacco and potato, was shown to enhance the oxidative metabolism of e.g. herbicides (Inui et al., 2000 (Inui et al., , 2001 ). In these experiments, co-expression of mammalian NADPH-P450 reductase was not necessary, since the foreign P450s were supplied with the requisite electrons by endogenous plant reductases. Recently, we similarly produced transgenic cell suspension cultures of tobacco overexpressing human P450 CYP1A1 or CYP1A2 (each under control of a constituitive promotor). These P450-transgenic in vitro systems were subsequently used to examine successfully the metabolism of atrazine and metamitron. In addition to metabolic pathways, it was shown that the main oxidized metabolites of both herbicides could be generated in 100Ð 200 µg amounts per cell culture assay (Bode, 2004; Bode et al., 2004) .
In the present investigation, this conception of 'oxidative metabolic profiling' is applied to the xenoestrogen (endocrine disruptor) nonylphenol, which emerges prevailingly in the environment or in foodstuffs as degradation product of nonylphenol polyethoxylates; these are used world-wide as e.g. detergents and emulsifiers (Thiele et al., 1997; Staples et al., 1999; Guenther et al., 2002) . Industrially produced nonylphenol contains about 90% of 4-nonylphenol, which consists of a mixture of branched-chain (C 9 ) isomers (Wheeler et al., 1997; Nakagawa et al., 2004; Ruß et al. 2005) . Though straight-chain 4-n-nonylphenol is rather not a component of industrially produced nonylphenol, a number of metabolism studies was performed with this model compound, e.g. in plant tissues Schmidt and Schuphan, 2002; Schmidt et al., 2003 Schmidt et al., , 2004 . The relevance of experiments with 4-n-nonylphenol is discussed Ð especially concerning endocrine and toxic effects.
However, we could demonstrate that in Agrostemma githago plant cell suspension cultures, similar metabolites were formed from straightchain 4-n-nonylphenol (Schmidt et al., 2003) and branched-chain 4-(3Ј,5Ј-dimethyl-3Ј-heptyl)-phenol (Schmidt et al., 2004) , which is a prominent component of the industrial mixture (Ruß et al., 2005) . The main metabolites formed by A. githago from both isomers were glycosides of the parent itself and of several side-chain hydroxylated (primary) metabolites. Part of the studies were executed in a two-liquid-phase system using n-hexadecane (0.5%, v/v) as carrier for application of higher amounts of the highly lipophilic nonylphenol isomers. On the whole, these findings make 4-n-nonylphenol an attractive nonylphenol model compound for the present metabolism studies with the CYP1A1-and CYP1A2-transgenic cell cultures of tobacco.
The objectives of the present investigation were to examine whether (i) 4-n-nonylphenol is biotransformed by non-modified tobacco cell suspension cultures (including metabolic profile), (ii) 4-n-nonylphenol is substrate of human CYP1A1 or CYP1A2 expressed in tobacco cell suspension cultures (including metabolic profile), and (iii) the concept of 'oxidative metabolic profiling' using P450-transgenic tobacco cell cultures can be applied to 4-n-nonylphenol. In order to obtain higher amounts of the metabolites, part of the studies were performed in a two-liquid-phase system described previously (Schmidt et al., 2003) .
Materials and Methods

Chemicals
[Ring-U- 14 C]-4-n-nonylphenol ( 14 C-4-n-NP; specific activity: 1,080.4 MBq mmol
Ð1
; radiochemical purity: > 98% due to HPLC analysis) was supplied by Hartmann Analytic (Braunschweig, Germany). Non-labelled 4-n-nonylphenol was provided by Promochem (Wesel, Germany). For the metabolism studies, the specific activity of the radio ; 200 µg assays).
Cell cultures and treatments
The P450-transgenic cultures (CYP1A1, CYP1A2) were produced from the corresponding non-transformed tobacco cell suspension cultures (Nicotiana tabacum L.; NT), which were provided by DSMZ (Braunschweig, Germany). Stable genetic transformation and cultivation of the cultures utilized for the studies were described (Bode, 2004; Bode et al., 2004) . The cultivation cycle of all cultures was 10 d; cultivation and metabolism studies were executed in 100 ml Erlenmeyer flasks. In the first study (20 µg assays), the cell suspensions were treated with 20 µg (1 ¥ 10 6 dpm, in 20 µl methanol) of 14 C-4-n-NP per assay 9 d after subcultivation, and were then incubated for 24 h. Cultures of the second study (200 µg assays) were treated with 200 µg (1.8 ¥ 10 6 dpm, in 100 µl nhexadecane) of 14 C-4-n-NP per assay; n-hexadecane constituted the organic phase of the two-liquid-phase system. These assays were then incubated for 192 h. The studies were executed using 2 (20 µg assays) or 3 parallels (200 µg assays).
Extraction procedures and initial analysis
Concerning the 20 µg assays, media were separated from cells by suction filtration and analyzed by liquid scintillation counting (LSC; LS 6500 analyzer, Beckman, Munich, Germany). The cells were stored in chloroform/methanol (1:2, v/v) at Ð 20 ∞C for 16 h and were extracted with this solvent mixture by means of sonication (Bandelin, Berlin, Germany). Insoluble cell debris were separated by suction filtration and washed with chloroform/methanol/water (1:2:0.8 v/v/v). Portions of 14 C contained in extracts were examined by LSC. Insoluble cell debris were air-dried and subjected to combustion analysis (Biological Oxidizer OX 500; Zinsser Instruments, Frankfurt, Germany) for the determination of non-extractable residues.
Concerning the 200 µg assays, entire assays were transferred to centrifuge tubes, and 10 ml of hexane were added in order to separate the n-hexadecane phases. After centrifugation (15 min, 5,000 ¥ g), organic phases were removed and subjected to LSC. Remaining media and cells were treated as described before (20 µg assays). The individual media and cell extracts were analyzed by TLC.
Hydrolysis procedure
Hydrolysis was performed using a mixture of 2 m HCl and methanol (1:1 v/v) for 2 h at reflux (Markham, 1982) . The methanol portion of the reaction mixture was then removed and the remaining aqueous phase was extracted with diethyl ether. Portions of 14 C found in extracts (designated as hydrolysates) and those in the aqueous phases were determined by LSC.
Chromatographic procedures
Analytic thin-layer chromatography (TLC) was performed on silica gel plates SIL G-25 UV 254 (0.25 mm) supplied by Macherey-Nagel (Düren, Germany). Solvent systems were A: n-hexane/diethyl ether/acetic acid 50:50:1 (v/v/v), B: ethyl acetate/iso-propanol 40:60 (v/v), C: ethyl acetate/isopropanol/water 64:24:4 (v/v/v), and D: n-hexane/ diethyl ether/acetic acid 20:80:1 (v/v/v). Occasionally, TLC plates were developed using systems A, B and C, successively. Separated 14 C spots were located and quantified using a Tracemaster 40 radiochromatogram scanner (Berthold, Wildbad, Germany); non-labelled 4-n-NP was detected under UV light at 254 nm.
High-performance liquid chromatography (HPLC) was performed on a Beckman System Gold Personal chromatograph (München, Germany) consisting of Programmable Solvent Module 126 and Diode Array Detector Modul 168. This system was connected to a Ramona 5 radiodetector equipped with a 1655 quartz cell (glass, 32Ð45 µm; internal diameter: 4.0 mm; cell volume: 0.4 ml) supplied by Raytest (Straubenhardt, Germany). All HPLC analyses were performed at 20 ∞C on a reversed phase column (CC 250/4 Nucleosil 100Ð5 C18 HD; Macherey-Nagel, Düren, Germany) using a flow of 1 ml min
Ð1
. Non-labelled 4-n-NP was detected at 280 nm. Elution was carried out with solvents A (0.1% acetic acid in water) and B (0.1% acetic acid in acetonitrile) as follows: A/B 65:35 (v/v) for 5 min, linear 30 min gradient to 100% B, isocratic B (100%) for 5 min, and return to initial conditions within 5 min. All HPLC analyses were performed with an injection volume of 100 µl and terminated by washing the column for 5 min with the initial solvent system. For isolation of metabolite fractions, same conditions were used with repeated collection of fractions at the outlet of the system. GC-EIMS was performed using a Hewlett-Packard 5890 Series II gas chromatograph (Agilent Technologies, Waldbronn, Germany) equipped with a FS-SE-54-NB-0.5 column (25 m ¥ 0.25 mm, 0.46 µm film thickness; CS Chromatographie Service, Langerwehe, Germany). The gas chromatograph was connected to a Hewlett-Packard 5971 A MSD (mass selective detector), which was operated in the scan mode (mass range m/z 50Ð500) with an electron energy of 70 eV. Carrier gas was helium, and injection volume was 1 µl.
Derivatization
Samples were derivatized with 100 µl of N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA; Fluka, Buchs, Switzerland) at 70 ∞C for 30 min in closed crimp cap vials. Reaction mixtures were directly injected into the GC-EIMS apparatus. Acetylation of samples was performed with 1 ml acetic acid anhydride and 1 ml pyridine overnight. Then, the anhydride and the solvent were removed under reduced pressure, and the remaining residue was dissolved in methanol for GC-EIMS injection. Derivatization with trimethyl orthoacetate was executed as follows: Samples were dissolved in 0.4 ml acetic acid anhydride, 0.1 ml acetic acid and 2 ml of trimethyl orthoacetate, and were heated to 105 ∞C for 4 h. Then, the solvent was removed, and the remaining residue was dissolved in methanol.
Results and Discussion
Distribution of radioactivity
Concerning the 20 µg assays (data not shown), the majority of 14 C was present in cell extracts (79.9Ð86.4% of applied radioactivity), while portions below 10% were detected in both, the media and cell debris. The recovered radioactivity was above 95% with all assays, which suggests that transformation of 14 C-4-n-NP to 14 CO 2 and volatile organics, or volatilization of parent 14 C-4-n-NP C-4-n-NP was present only in minor amounts (non-transformed tobacco cultures, NT: 4.4%; cyp1a1-transformed cultures, CYP1A1: 12.6%) or completely absent (cyp1a2-transformed cultures, CYP1A2). The chromatographic behaviour of 14 C contained in all cell extracts with systems AÐD pointed to glycosides as metabolic products.
Regarding the 200 µg assays of the two-liquidphase study (Table I) , 21.6Ð34.8% of applied 14 C were detected in media and 41.2Ð58.8% in cell extracts. Remaining portions were associated with cell debris (2.6Ð14.8%) or n-hexandecane phases. While recoveries of 14 C were above 90%, free 14 C-4-n-NP was found in none of the 200 µg assays. As with the 20 µg assays, the radioactivity in the cell extracts appeared to consist of glycosides (TLC solvent systems B and C). With all TLC systems used, the radioactivity in the media proved to be immobile. Extraction of these 14 C portions with organic solvents was not successful; the same held true for hydrolysis procedures in order to cleave possible glycosidic or ester linkages. HPLC analysis was not practicable, since the necessary concentration of the media resulted in highly viscous samples.
Concerning distribution of 14 C, the results obtained with the non-modified and P450-transgenic tobacco cells were comparable to data published recently on the biotransformation of 4-n-NP and the branched-chain isomer 4-(3Ј,5Ј-dimethyl-3Ј-heptyl)-phenol by Agrostemma githago cells Ð also using the same two-liquid-phase system (Schmidt et al., 2003 (Schmidt et al., , 2004 . Uptake of 4-n-NP from the n-hexadecane layer by the tobbacco cells was considered satisfactory. The same held for recoveries of 14 C, noticeable portions of soluble 14 C in the cell extracts and complete disappearance (turnover) of applied 4-n-NP. Generally, the formation of glycosides from the phenolic xenobiotic or its possible primary transformation products was expected according to data published on nonylphenol Schmidt and Schuphan, 2002; Schmidt et al., 2003 Schmidt et al., , 2004 . The chemical nature of the radioactivity present in the media remained obscure. Recently, 14 C materials with similar behaviour were found in media after application of 4-(3Ј,5Ј-dimethyl-3Ј-heptyl)-phenol and suspected to consist of polymerized or copolymerized products of the isomer (Schmidt et al., 2004) .
Hydrolysis of conjugates and isolation of primary 4-n-NP metabolites
The cell extracts of parallels were combined and subjected to hydrolysis (2 m HCl/methanol, reflux), in order to release the expected 14 C-aglycons from their corresponding glycosides. With both, the 20 and 200 µg assays, almost 100% of the radioactivity introduced in the hydrolysis experiments was recovered in the corresponding hydrolysates (diethyl ether extracts of reaction mixtures). Minor losses were observed after concentration. All hydrolysates were examined using TLC (systems A and D) and HPLC. The results of HPLC analysis demonstrated ( Fig. 1 ; samples derived from 200 µg assays) that similar peak patterns (R t 15Ð 30 min) were obtained from the NT, CYP1A1 and CYP1A2 cultures. All peaks were preponderantly absent before hydrolysis; thus the corresponding compounds were liberated from their glycosides by acid treatment.
The peak with R t 26Ð29 min (fraction 3) was traced back to the parent by cochromatography with authentic C-4-n-NP. In the hydrolysates derived from the 200 µg assays, corresponding portions were prevailingly higher (as compared to the 20 µg assays) with a maximum value of about 75% in case of the CYP1A1 culture. Based on applied radioactivity however, percentages of primary metabolites were lower in the 200 µg assays (Table I) due to lower 14 C portions detected in the cell extracts. This fact may be referred to the extended incubation interval (24 h vs. 192 h) and consequently further biotransformation steps with regard to applied 14 C-4-n-NP. Nevertheless, total amounts of primary metabolites (fractions 1 and 2) produced by the NT, CYP1A1 and CYP1A2 cultures were about 60 µg, 80 µg and 40 µg per 200 µg assay, respectively. The radioactivity contained in the hydrolysates of the 200 µg assays was separated using multiple HPLC runs for fraction 1 (R t 15Ð18 min), 2 (R t 21Ð25 min) and 3 (R t 26Ð29 min).
Identification of 4-n-NP metabolites by GC-EIMS
According to previously published data on 4-n-NP and a 4-NP isomer (Schmidt et al., 2003 (Schmidt et al., , 2004 , the isolated HPLC fractions 1 and 3 were reacted with MSTFA to trimethylsilyl derivatives. These were examined by GC-EIMS. In fractions 1 isolated from both, the genetically non-modified and the two P450-transgenic tobacco cultures, 13 peaks (I to XIII) were detected ( Fig. 2A) , which could be traced back to 4-n-NP. Due to their mass spectra, peaks I to V were identified by the side-chain hydroxylated products 4Ј-OH-4-n-NP to 8Ј-OH-4-n-NP (Table II) . A thorough dicussion of these mass spectra was published recently (Schmidt et al., 2003) . Prominent fragments were m/z 290 resulting from cleavage of HOSi ( Table II . EI mass spectra (trimethylsilyl derivatives) and portions of 4-n-nonylphenol (4-n-NP) and its metabolites observed in HPLC fractions 1 (R t 15Ð18 min) and 3 (R t 26Ð29 min), which were derived from the hydrolysates of the non-transformed (NT) and P450-transgenic (CYP1A1, CYP1A2) tobacco cell suspension cultures. Abundance of mass spectral fragments was determined from data of CYP1A1 culture; percentages were based on peak area; total area of peaks detected in the fraction corresponds with 100%. (8), 179 (7), 157 (20), 131 (27), 73 (100) 4-n-NenP (63) a Structures of 4-n-nonylphenol metabolites are proposed according to EIMS fragmentation patterns: 4Ј-OH-4-n-NP to 8Ј-OH-4-n-NP: side-chain hydroxylated derivatives of 4-n-NP; 6Ј-OH-4-n-NenP to 9Ј-OH-4-n-NenP: sidechain hydroxylated olefinic derivatives of 4-n-NP; 7Ј-OH-ring-OCH 3 -4-n-NP and 8Ј-OH-ring-OCH 3 -4-n-NP: sidechain hydroxylated and ring methoxylated derivatives of 4-n-NP; 7Ј-OH-ring-OCH 3 -4-n-NenP and 8Ј-OH-ring-OCH 3 -4-n-NenP: side-chain hydroxylated and ring methoxylated olefinic derivatives of 4-n-NP; 4-n-NeP: olefinic derivative of 4-n-NP. b Position of double bond in nonenyl derivatives (NenP) and position of OCH 3 substitution of the aromatic ring could not be identified. c Detected as shoulder; integration was not possible.
GC-MS EIMS
Similarily, peaks VI, VII, VIII and XI were regarded as signals of side-chain hydroxylated olefinic metabolites 6Ј-OH-4-n-NenP to 9Ј-OH-4-nNenP. The double bonds appeared to be located between the respective side-chain OH function and the aromatic ring, though exact positions remained unclear. The same holds for their origin. Both, enzymatic catalysis in the cells or chemical reactions, e.g. during hydrolysis (HCl/methanol at reflux), may have lead to formation of alkenes most probably from intermediary doubly hydroxylated products. The mass spectral fragmentation of 6Ј-OH-4-n-NenP was interpreted as follows (values . A similar mass spectrum was obtained for 8Ј-OH-ring-OCH 3 -4-n-NP with m/z 117, (CH 3 ) 3 SiOCHCH 3 +• indicating the position of side-chain OH. According to analogous argumentation, peaks XII and XIII were regarded as signals of 7Ј-OH-ring-OCH 3 -4-n-NenP and 8Ј-OH-ring-OCH 3 -4-n-NenP.
With HPLC fraction 3, two 4-n-NP derived peaks were observed ( Fig. 2B ; Table: II) in all three tobacco cell cultures examined: parent 4-n-NP itself (XIV) and olefinic 4-n-NenP (XV). The mass spectrum of 4-n-NP derived from the metabolism experiments corresponded with that of an authentic reference (both as trimethylsily derivatives). 4-n-NenP's mass spectrum was similar to that of parent 4-n-NP Ð however with base peak at m/z 205 (as compared to m/z 179 in case of 4-n-NP). This fact may indicate that the olefinic bond was located between C-2Ј and C-3Ј of the side-chain.
Since transformation products of 14 C-4-n-NP corresponding with fraction 2 were not detected in previous studies using several plant cell cultures (Schmidt et al., 2003; Schmidt and Schuphan, 2002) , different derivatization strategies were employed in order to examine these fractions by GC-EIMS. Due to similar chromatographic behaviour during HPLC and TLC (discussed later), it was assumed that roughly similar products were contained in fractions 2 obtained from the NT, CYP1A1 and CYP1A2 cultures. Fraction 2 resulting from NT cultures was trimethylsilyl derivatized (MSTFA). In the GC-EIMS chromatogram (Fig. 2C) , three peaks (XVIÐXVIII) were identified which were traced back to applied 14 C-4-n-NP (Table III) Fraction 2 derived from the CYP1A1 culture was acetylated. In the GC-EIMS chromatogram, one peak was detected which was related to 14 C-4-n-NP (Table III) . Due to its M +• at m/z 276, the compound was identified by the acetate of keto-4-n-NP. Further characteristic peaks appeared at m/z 234 (-COCH 2 ), 179 (234ÐC 4 H 7 ), 137 (179ÐC 3 H 6 ), and 123 (137ÐCH 2 ). The latter two fragments corresponded with m/z 209 and 195, respectively, of the trimethylsily derivatized sample (NT cultures). In fraction 2 (reacted with trimethyl orthoacetate) obtained from the CYP1A2 culture, only 4-n-NP was found either free or as acetate (Table III) . Their mass spectra agreed with those of authentic Table III . EI mass spectra (derivatives as indicated below) and portions of 4-n-nonylphenol (4-n-NP) and its metabolites observed in HPLC fraction 2 (R t 21Ð25 min) derived from the hydrolysates of the non-transformed (NT) and P450-transgenic (CYP1A1, CYP1A2) tobacco cell suspension cultures. Portions were based on peak area; total area of peaks detected in the fraction corresponds with 100%.
GC-MS
EIMS m/z (abundance in %) Compound a the 20 µg experiment, a total of 29.3% of primary metabolites were detected in the NT, 34.3% in the CYP1A1, and 50.7% in the CYP1A2 culture (values based on applied 14 C). These data were supported by results of TLC analysis. Taking into account the unidentified products contained in media and the non-extractable 14 C, which both may have been formed from primary metabolites, differences become even more distinct (HPLC: 41.0%, 51.3% and 66.0%, respectively). These results prove that 4-n-NP is metabolized to a higher extent to primary metabolites by the CYP1A1 and CYP1A2 cultures as compared to the NT culture. The endogenous capacity of the tobacco cells to form primary metabolites of the xenobiotic, however, appears to be noticeably higher than that of CYP1A1 or CYP1A2. According to corresponding data of the 200 µg assays, only culture CYP1A1 demonstrated a higher turnover than the NT culture. On the whole, the results of the 200 µg experiment were not as clear-cut as those from the 20 µg experiment; this ambiguous finding was referred to the rather artificial two-liquid-phase system and longer incubation interval utilized in this study. Using recombinant yeast microsomes expressing human P450 isozymes, Inui et al. (2001) found that 4-n-NP was substrate of CYP1A2 (besides CYP2B6 and CYP2C19) but not of CYP1A1. Involvement of P450s in the metabolism of (branched-chain) 4-nonylphenol was concluded from in vivo and in vitro studies with rainbow trout (Mehldahl et al., 1996) and pond snails (Lalah et al., 2003a, b) . Lee et al. (1998) studied the transformation of three branched-chain isomers in rat and human microsomes. By means of specific inducers and inhibitors, the authors demonstrated that CYP2B isozymes (of both, rats and humans), especially CYP2B2, are predominant in nonylphenol metabolism. Due to results published by Lee et al. (1996a, b) , nonylphenol may be substrate of rat hepatic CYP1A and CYP3A isozymes, whereas data reported by Mehldahl et al. (1996) indicated that rainbow trout CYP1A1 is not responsible for nonylphenol biotransformation. The present results partly agree with these Ð inconsistent Ð literature data; our results clearly suggest that 4-n-NP is transformed by CYP1A1 and CYP1A2; the xenobiotic, however, seems to be a poor substrate of both P450s.
The metabolic profiles of 4-n-NP metabolism in the CYP1A1, CYP1A2 and NT cultures were determined by GC-EIMS analysis of HPLC fraction 1Ð3, which were derived from the 200 µg assays. Concentrations of metabolites were too low in order to perform a thorough analysis with corresponding fractions from the 20 µg experiment. The data proved that the primary 4-n-NP metabolites identified with HPLC and TLC analysis were unequivocally produced by oxidative reactions, and that similar profiles were obtained from the CYP1A1, CYP1A2 and NT cultures. In all cell cultures studied, the main metabolites detected in fraction 1 were side-chain mono-hydroxylated derivatives of 4-n-NP with 6Ј-, 7Ј-and 8Ј-OH-4-n-NP as main products. This finding mainly agrees with data published previously on the metabolism of nonylphenol in plant tissues Bokern und Harms, 1997; Schmidt and Schuphan, 2002; Schmidt et al., 2003 Schmidt et al., , 2004 . Besides olefinic hydroxy derivatives described before Schmidt et al., 2003) , ring methoxylated derivatives were detected, which were thought to originate from the hydroxylated precursors. The lack of distinct differences among the CYP1A1, CYP1A2 and NT cultures concerning the metabolic profile of 4-n-NP may be due to the low enzymatic activity of CYP1A1 and CYP1A2 towards 4-n-NP, which was possibly covered by endogenous oxidative capacities of the tobacco cells. It is additionally conceivable that CYP1A1 and CYP1A2 produced similar 4-n-NP metabolic profiles as the tobacco suspension itself (i.e. culture NT). Mehldahl et al. (1996) reported that several nonylphenol isomers were transformed to sidechain hydroxy derivatives by rainbow trout. Similar products were suspected from studies with rat and human hepatic microsomes (Lee et al., 1998) . In trout, 4-n-NP was shown to be metabolized to ring or side-chain hydroxylated metabolites (Coldham et al., 1998) , while Inui et al. (2001) similarly demonstrated that human CYP1A2 expressed in yeast microsomes transformed the compound to ring or side-chain hydroxylated derivatives. Lalah et al. (2003a, b) found a catechol derivative of a branched-chain nonylphenol isomer after exposure to pond snails. A glucuronide of a catechol derivative was also reported by Doerge et al. (2002) following administration of nonylphenol to rats.
